Adverum Biotechnologies, Inc.   Report issue

For profit Phase 2
Founded: Menlo Park CA United States (2006)

Organization Overview

First Clinical Trial
2011
NCT01494805
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Adverum Biotechnologies, Inc. | Avalanche Biotechnologies, Inc.